<?xml version="1.0" encoding="UTF-8"?>
<ref id="B16">
 <label>16</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Song</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Cheng</surname>
    <given-names>JW</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>YF</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>KQ</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>PX</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Anlotinib suppresses tumor progression 
   <italic>via</italic> blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma
  </article-title>. 
  <source>Cell Death Dis</source> (
  <year>2020</year>) 
  <volume>11:573</volume>. Â 
  <pub-id pub-id-type="doi">10.1038/s41419-020-02749-7</pub-id>
 </mixed-citation>
</ref>
